On Tuesday, General Electric Company (NYSE:GE)’s shares inclined 0.04% to $25.10.
A new collaboration, declared recently, between GE Healthcare Canada and BIOTIC will initiate a Halifax -based research and development (R&D) and technology commercialization program with the aim of bringing software technology advances to medical imaging.
The partnership draws on the recent acquisition of GE Healthcare’s 3T magnetic resonance imaging (MRI) technology at the QEII Health Sciences Centre (QEII) and BIOTIC’s expertise in medical imaging based technology development, to explore the application of advanced software solutions to better diagnose and treat diseases of the brain, liver and prostate.
The aim of this partnership is to validate and commercialize software-powered medical imaging technology for eventual world-wide use as added solutions and features to GE Healthcare’s MRI systems. Each products is being developed as “pushbutton”- improving efficiency, comprising and accuracy of the MRI results - potentially improving care for patients in Nova Scotia and around the world.
General Electric Company (GE) operates as an infrastructure and financial services company worldwide. The company’s Power and Water segment offers gas, steam and aeroderivative turbines, nuclear reactors, generators, combined cycle systems, controls, and related services; wind turbines; and water treatment services and equipment. Its Oil and Gas segment provides surface and subsea drilling and production systems, equipment for floating production platforms, compressors, turbines, turboexpanders, reactors, industrial power generation, and auxiliary equipment.
ConAgra Foods Inc (NYSE:CAG)’s shares dropped -7.03% to $39.42.
ConAgra Foods, Inc., (CAG) stated results for the fiscal 2016 first quarter ended August 30, 2015.
Highlights (% cited indicates change vs. year-ago amounts, where applicable. SG&A refers to selling, general, and administrative expense, and COGS refers to cost of goods sold)
- Diluted EPS from ongoing operations as stated was $0.38, contrast to $0.22 in the year-ago period. After adjusting for items impacting comparability, diluted comparable EPS of $0.45 this quarter exceeded $0.39 in the year-ago period.
- Consumer Foods posted strong operating profit growth and more than 250 basis points of comparable margin improvement through a combination of favorable price/mix and raised productivity.
- Commercial Foods posted good sales and operating profit performance, primarily due to strong volumes, favorable mix, and efficiencies for Lamb Weston.
ConAgra Foods, Inc. operates as a food company primarily in North America. The company operates through three segments: Consumer Foods, Commercial Foods, and Private Brands. The Consumer Foods segment provides branded food products in various categories, such as meals, entrees, condiments, sides, snacks, and desserts to various retail channels, such as frozen, refrigerated, and shelf-stable temperature classes.
At the end of Tuesday’s trade, E I Du Pont De Nemours And Co (NYSE:DD)‘s shares surged 0.64% to $48.55.
DuPont has named Rose Lee as president of its Protection Technologies business effective October 1, reporting to DuPont Senior Vice President Marc Doyle.
Lee has served as global business director, DuPont™ Kevlar® and Aramid Intermediates. Proceeding to DuPont, Lee was vice president and general manager, Innovative Materials, for Saint-Gobain Corporation. She has held business and functional leadership roles at Saint-Gobain, Booz Allen & Hamilton and the Pratt & Whitney division of United Technologies.
Lee served as a member of the Economic Advisory Council for the Federal Reserve Bank of Philadelphia, Inc. She holds a B.S. degree in Engineering from Cornell University, and an M.S. in Engineering from Rensselaer Polytechnic Institute and an M.B.A. from Massachusetts Institute of Technology.
E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, seed products, wheat, rice, herbicides, fungicides, and insecticides.
Plug Power Inc (NASDAQ:PLUG), ended its Tuesday’s trading session with 0.46% gain, and closed at $2.18.
Plug Power Inc. (PLUG), has formed Plug Power Capital Inc., a wholly owned partner of Plug Power, formed as a capital financing arm that will offer GenFund, giving customers easy access to third-party leases.
Through GenFund, Plug Power Capital will work with its customers and commercial banks, facilitating project funding for the purchase of Plug Power Inc. hydrogen and fuel cell solutions.
Plug Power’s GenKey solution combines all the critical elements for a full hydrogen and fuel cell deployment, counting GenDrive or ReliOn fuel cell power, GenFuel hydrogen and fueling infrastructure, and GenCare aftermarket support.
As the newest element to this equation, GenFund will expedite deal closure, providing yet another aspect of GenKey that makes it a convenient, one-stop source for Plug Power hydrogen and fuel cell implementations. GenFund will be offered to both material handling and stationary customers through GenKey, and will also be available on an individual-case basis to assist other non-GenKey customers.
Plug Power Inc., an alternative energy technology provider, engages in the design, development, manufacture, and commercialization of fuel cell systems for the industrial off-road markets worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
